A Review on Semaglutide: An Oral Glucagon-Like Polypeptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
mediaposted on 2020-07-24, 16:07 authored by Sanjay Kalra, Rakesh Sahay
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.